|
2024
|
Invention
|
Isotopically enriched n-methyl-1,3-benzodioxolylbutanamine (mbdb) and stereoisomers thereof.
Dis... |
|
|
Invention
|
Phenethylamine compounds salts, polymorphic forms and methods of use thereof.
Disclosed herein a... |
|
|
Invention
|
Analogs of n,n,n-trimethyl-4-phosphoryloxytryptamine.
Deuterium-containing analogs/derivatives o... |
|
|
Invention
|
Prodrugs of xanomeline, prodrugs of trospium and methods of use thereof. Disclosed herein are xan... |
|
|
Invention
|
N- dimethylpropan-2-amine or a pharmaceutically acceptable salt thereof. The present disclosure p... |
|
|
Invention
|
Pharmaceutical compositions comprising methylone or a pharmaceutically acceptable salt thereof. T... |
|
|
Invention
|
Analogs of xanomeline.
Disclosed herein are xanomeline analogs, as well as methods for making an... |
|
2023
|
Invention
|
N,n-dimethyltryptamine and related psychedelics and uses thereof.
Described herein are compounds... |
|
|
Invention
|
Psilocybin and o-acetylpsilocin, salts and solid state forms thereof. Disclosed herein are salts ... |
|
|
Invention
|
Combination product for the treatment of neurological and/or psychiatric disorders.
The present ... |
|
|
Invention
|
Combination product for the treatment of neurological and/or psychiatric disorders.
Combination ... |
|
|
Invention
|
Methods for acquiring and analyzing neuromelanin-sensitive mri. A neuromelanin sensitive magnetic... |
|
|
Invention
|
Neuromelanin-sensitive mri and methods of use thereof.
A neuromelanin sensitive magnetic resonan... |
|
|
Invention
|
Salts and solid forms of (r)-1-(5-methoxy-1h-indol-1-yl)-n,n-dimethylpropan-2-amine.
The present... |
|
|
Invention
|
Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychi... |
|
|
Invention
|
Phenethylamine compounds salts, polymorphic forms and methods of use thereof. Disclosed herein ar... |
|
|
Invention
|
N,n-dimethyltryptamine and related psychedelics and uses thereof. Described herein are compounds ... |
|
|
Invention
|
Deuterated idazoxan and methods of use thereof. Deuterated forms of idazoxan according to Formula... |
|
|
Invention
|
Isotopologes, salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of u... |
|
|
Invention
|
N-methylethan-1-amine. NNNNNNNNN-methylethan-1-amine are useful for treating neurological disease... |
|
|
Invention
|
Prodrugs of 2-bromo-lsd (2-bromolysergic acid diethylamide). Disclosed herein are 2-bromo-LSD ana... |
|
|
Invention
|
Functionalized alkylamines. 2A2A receptor, or to increase at least one of translation, transcript... |
|
|
Invention
|
Prodrugs of 3,4-methylenedioxy-n-methcathinone and uses thereof. The present disclosure relates t... |
|
|
Invention
|
N-ethyl-amphetamine (mdea) and uses thereof. The present disclosure relates to prodrugs of 3,4-me... |
|
|
Invention
|
N,n-diisopropyltryptamine hemi-glutarate and hemi-succinate. N,NN,N-diisopropyltryptamine hemi-gl... |
|
|
Invention
|
A process for synthesizing ketanserin. Disclosed herein is a process for synthesizing ketanserin ... |
|
2022
|
Invention
|
Salt and solid forms of ketanserin. The disclosure relates to forms of ketanserin, including soli... |
|
|
Invention
|
Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of u... |
|
|
Invention
|
Analogs of 4-bromo-2,5-dimethoxyphenethylamine.
The present disclosure relates to compound Formu... |
|
|
Invention
|
Analogs of 4-bromo-2,5-dimethoxyphenethylamine. The present disclosure relates to compound Formul... |
|
|
Invention
|
Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsd. Disclosed herein are isoto... |
|
|
Invention
|
Analogs of 4-substituted-2,5-dimethoxyamphetamine. Disclosed herein are compounds of the formula ... |
|
|
Invention
|
N-dimethyltryptamine. The present disclosure relates to compound Formula (I): or an enantiomer, a... |
|
|
Invention
|
Salt and solid forms of indole analogs and methods of use thereof. Disclosed herein are salts and... |
|
|
Invention
|
Salt and solid forms of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (dom), 2,5-dimethoxy-4-io... |
|
|
Invention
|
Salt and solid forms of lysergic acid diethylamide (lsd) and analogs. Disclosed herein are salts ... |
|
|
Invention
|
Salt and solid forms of tabernanthalog.
Disclosed herein are salt and solid forms of tabernantha... |
|
|
Invention
|
Psilocybin and o-acetylpsilocin, salts and solid state forms thereof.
Disclosed herein are salts... |
|
|
Invention
|
Isotopically enriched analogs of 5,6-methylenedioxy-2-aminoindane (mdai).
Disclosed herein are i... |
|
|
Invention
|
N-substituted indoles.
Disclosed herein are compounds of the formula
Disclosed herein are comp... |
|
|
Invention
|
Methods and compositions relating to controlling psychedelic effects with serotonin receptor modu... |
|
|
Invention
|
Processes of preparing psilocin and psilocybin.
Described herein are processes for preparing psi... |
|
|
Invention
|
Prodrugs and derivatives of psilocin and uses thereof.
Described herein are compounds that are d... |
|
|
Invention
|
Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof.
Prov... |
|
|
Invention
|
3,4-methylenedioxymethamphetamine and related psychedelics and uses thereof.
Described herein ar... |
|
|
Invention
|
Methods and compositions relating to psychedelics and serotonin receptor modulators.
Provided he... |
